MediValve, Ltd., a Trendlines portfolio company, announced that it has successfully completed the first two cases of post-market clinical evaluation of its acWire Guidewire[1],[2],[3]. The acWire is intended for use in peripheral vascular and heart catheterization procedures to introduce and assist in positioning diagnostic and interventional devices. The acWire may...
Read more
Blog
Gour Medical Animal Health Gets New Products
Gour Medical Animal Health, which recently agreed to acquire a portfolio of four human health products to be reformulated for pet care, is also negotiating for three or four additional products. See full article on BioTuesdays http://biotuesdays.com/2014/04/08/gour-medical-in-talks-to-expand-animal-health-portfolio/...
Read more
China Everbright to Invest $100 M in Israeli Co.’s
China Everbright Ltd (CEL) and Israel’s Catalyst Equity Management have raised $100 million for a private equity fund that will invest in Israeli companies. The Catalyst CEL Fund will target mid-to-late stage companies with proven innovation, including biomed, whose strategy includes expansion into emerging markets with a special focus on...
Read more
Largest Gene Synthesis Provider To Debut at Biotech China
GenScript , the largest gene synthesis provider in the U.S, and a leading biology CRO in the world, has confirmed participation at 2014 Biotech China. GenScript is a leading biology CRO focusing exclusively on early drug discovery and development services. Built on an assembly-line mode, one-stop solution, continuous improvement, and...
Read more
Israel’s MD Biosciences Among CROs at Biotech China
MD Biosciences is a pre-clinical contract research organization (CRO) providing in vitro and in vivo nonclinical efficacy studies as well as a clinical biomarker and general chemistry analysis. The company’s focus is on inflammation, neurological and cardiovascular conditions. MD BioSciences’ approach is to understand the need in the clinic and...
Read more